Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Abe

Showing results (461-470 of 623) with videos related to

Pageof 63
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1996
[A randomized controlled study of maintenance therapy with (2"R)-4'-O-tetrahydropyranyladriamycin for advanced and recurrent breast cancer. Clinical Study Group of THP for Breast Cancer in Japan]K Enomoto, T Tominaga, R Abe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1993
[S-phase fraction and malignant potential in DNA diploid colorectal cancer]Y Ando, A Tsuchiya, F Watanabe, et al.
The Tohoku Journal of Experimental Medicine|October 1, 1983
Mass screening for breast cancerR Abe, A Sakuma, K Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1987
[HTLV-I associated myelopathy (HAM) in Fukushima Prefecture]M Mita, I Konno, M Kawaguchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28K Saito, J Sakurai, J Ohata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[An experimental study of the efficacy of platelet aggregating inhibitor on hepatic metastasis]Y Koyama, M Hoshino, T Yamaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy]M Hoshino, Y Koyama, W Igarashi, et al.
The Journal of Experimental Medicine|September 28, 1999
Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tailC Nakaseko, S Miyatake, T Iida, et al.
Diabetes Care|October 20, 1999
Effect of exercise training on doses of oral agents and insulinH Fujinuma, R Abe, T Yamazaki, et al.
The Journal of Investigative Dermatology|June 16, 2001
High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasisT Shimizu, J Nishihira, Y Mizue, et al.
Pageof 63

Showing results (461-470 of 623) with videos related to

Sort By:
Pageof 63
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1996
[A randomized controlled study of maintenance therapy with (2"R)-4'-O-tetrahydropyranyladriamycin for advanced and recurrent breast cancer. Clinical Study Group of THP for Breast Cancer in Japan]K Enomoto, T Tominaga, R Abe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1993
[S-phase fraction and malignant potential in DNA diploid colorectal cancer]Y Ando, A Tsuchiya, F Watanabe, et al.
The Tohoku Journal of Experimental Medicine|October 1, 1983
Mass screening for breast cancerR Abe, A Sakuma, K Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1987
[HTLV-I associated myelopathy (HAM) in Fukushima Prefecture]M Mita, I Konno, M Kawaguchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28K Saito, J Sakurai, J Ohata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[An experimental study of the efficacy of platelet aggregating inhibitor on hepatic metastasis]Y Koyama, M Hoshino, T Yamaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy]M Hoshino, Y Koyama, W Igarashi, et al.
The Journal of Experimental Medicine|September 28, 1999
Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tailC Nakaseko, S Miyatake, T Iida, et al.
Diabetes Care|October 20, 1999
Effect of exercise training on doses of oral agents and insulinH Fujinuma, R Abe, T Yamazaki, et al.
The Journal of Investigative Dermatology|June 16, 2001
High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasisT Shimizu, J Nishihira, Y Mizue, et al.
Pageof 63